Patent · US Expired

Conjugates of methyltrithio antitumor agents and intermediates for their synthesis

US5773001A · kind A · utility

404Cited by
5References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 1994
Grant dateJun 30, 1998
Priority date
Expiry dateJun 3, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention describes carrier-drug conjugates prepared from disulfide analogs of the calicheamicin family of potent antitumor antibiotics and their derivatives, as well as similar analogs from related antitumor antibiotics such as the esperamicins. The carrier can be an antibody, growth factor, or steroid which targets an undesired population of cells, such as those of a tumor. Whole protein carriers as well as their antigen-recognizing fragments and their chemically or genetically manipulated counterparts are useful for the targeting portion of the conjugates. This invention includes compounds required for the synthesis of these conjugates, appropriate pharmaceutical compositions of the carrier-drug conjugates, and their method of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.